Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-11 21:33 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Efficacy Study of Cardizem in Pulmonary Arterial Hypertension
NCT01645826 · University of South Florida · NA · withdrawn · last registry update 2018-11-20 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
What was said, and by whom
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | “no participants agreed to enroll since study start” | – | Registry record, University of South Florida |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against CACNA1C within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2019-09-18Also stopped (withdrawn): Johns Hopkins University, Nimodipine + Verapamil ER (NCT03150524)
- 2019-08-26Results posted on the registry: Mayo Clinic, Rate or Rhythm Control Therapy (NCT00911508)
- 2019-07-30Phase 3 first posted: University of Pennsylvania, Anti Arrhythmics (NCT04037397)
- 2019-07-23Also stopped (terminated): Benjamin Bleier, Verapamil Hydrochloride Intranasal (NCT03102190)
- 2019-07-12Results posted on the registry: Boehringer Ingelheim, Digoxin + Furosemide (NCT03307252)
- 2019-06-21Results posted on the registry: Benjamin Bleier, Verapamil Hydrochloride Intranasal (NCT03102190)
- 2019-04-05Phase 3 first posted: doaa rashwan, Dronedarone + Amiodarone (NCT03905759)
- 2019-01-30Results posted on the registry: University of Alabama at Birmingham, Verapamil + Placebo (NCT02372253)
- 2019-01-23Phase 3 first posted: EMS, LENINGRADO association + Indapamide SR 1.5 MG (NCT03814109)
- 2018-08-09Phase 3 first posted: Hermina Heart Center Kemayoran, Nitroglycerin (NCT03622060)
- 2018-06-26Phase 3 first posted: Samsung Medical Center, Edoxaban + Enoxaparin (NCT03570281)
- 2018-06-14Also stopped (terminated): Benjamin Bleier, Verapamil HCl (NCT02454608)
- 2018-04-11Also stopped (terminated): Center Laboratories, Inc., R-verapamil 75 mg tablet + Placebo (NCT02209155)
- 2018-02-23Results posted on the registry: AstraZeneca, AZD7986 + Verapamil (NCT02653872)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision